Durvalumab (durva) plus carboplatin/paclitaxel (CP) followed by maintenance (mtx) durva +- olaparib (ola) as a first-line (1L) treatment for newly diagnosed advanced or recurrent endometrial cancer (EC): Results from the phase III DUO-E/GOG-3041/ENGOT-EN10 trial
Carboplatin;Durvalumab;Olaparib;Paclitaxel
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Durvalumab (durva) plus carboplatin/paclitaxel (CP) followed by maintenance (mtx) durva +- olaparib (ola) as a first-line (1L) treatment for newly diagnosed advanced or recurrent endometrial cancer (EC): Results from the phase III DUO-E/GOG-3041/ENGOT-EN10 trial ### Output: Carboplatin;Durvalumab;Olaparib;Paclitaxel